Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma: A quantitative morphologic analysis

Virchows Archiv

Volumn 440, Issue 1, 2002, Pages 22-28

  Massi, Daniela ^a   Franchi, Alessandro ^a   Borgognoni, Lorenzo ^b   Paglierani, Milena ^a   Reali, Umberto Maria ^b   Santucci, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Azienda Sanitaria di Firenze   (Italy)

Author keywords

Angiogenesis; Image analysis; Melanoma; Morphometry; Neovascularization; Prognosis

Indexed keywords

CD31 ANTIGEN;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; MALE; MELANOMA; METASTASIS; MICROVASCULATURE; MORPHOLOGY; MORPHOMETRICS; NEOVASCULARIZATION (PATHOLOGY); PERIMETER; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; RANK SUM TEST; RECURRENT DISEASE; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VASCULAR TUMOR;

ADULT; AGED; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SKIN NEOPLASMS;

EID: 0036170155     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280100480     Document Type: Article

References (24)

1. An analysis of prognostic factors in 8500 patients with cutaneous melanoma
2. Regressing thin cutaneous malignant melanomas (≤1.0 mm) are associated with angiogenesis
3. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma
4. Thickness, cross-sectional area and depth of invasion in the prognosis of cutaneous melanoma
5. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin
6. The vascularity of cutaneous melanoma: A quantitative histological study of lesions 0.85-1.25 mm in thickness
7. The histogenesis and biologic behaviour of primary human malignant melanomas of the skin
8. Model predicting survival in stage I melanoma based on tumor progression
9. Lack of lymphangiogenesis in human primary cutaneous melanoma. Consequences for the mechanism of lymphatic dissemination
10. What is the evidence that tumors are angiogenesis dependent?
11. Induction of angiogenesis during the transition from hyperplasia to neoplasia
12. Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas
13. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
14. Prognostic value of tumor vascularity in primary melanoma
15. Thick cutaneous malignant melanoma: A reappraisal of prognostic factors
16. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens: Evaluation of their specificity and sensitivity in the diagnosis of vascular tumors in comparison with von Willebrand factor
17. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections
18. Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma
19. Prognostic index in malignant melanoma
20. Cutaneous thick melanoma. Prognosis and treatment
21. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma
22. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
23. Intratumoral microvessel density as a prognostic factor in cancer
24. Tumoural vascularity as a prognostic factor in cancer patients: The evidence continues to grow